Home › Trial NCT03752099
To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
- Trial IDNCT03752099
- StatusTerminated
- PhasePhase 1/2
- Study typeInterventional
- SponsorVeru Inc.
- Enrollment80
- Start date2019-01-18
- ConditionsMetastatic Castration Resistant Prostate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.